Last reviewed · How we verify

Chloromycetin Palmitate — Competitive Intelligence Brief

Chloromycetin Palmitate (chloramphenicol palmitate) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amphenicol-class Antibacterial. Area: Infectious Disease.

marketed Amphenicol-class Antibacterial Infectious Disease Live · refreshed every 30 min

Target snapshot

Chloromycetin Palmitate (chloramphenicol palmitate).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Chloromycetin Palmitate TARGET chloramphenicol palmitate marketed Amphenicol-class Antibacterial
Chloromycetin chloramphenicol succinate Parkedale marketed Amphenicol-class Antibacterial 1950-01-01
Chlorocidin CHLORAMPHENICOL Parkedale marketed Amphenicol-class Antibacterial Cytochrome P450 3A4 1950-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amphenicol-class Antibacterial class)

  1. Parkedale · 2 drugs in this class
  2. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chloromycetin Palmitate — Competitive Intelligence Brief. https://druglandscape.com/ci/chloramphenicol-palmitate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: